Aier Eye Hospital Group Co., Ltd.
300015
株式のランク
#1964
Aier Eye Hospital Group Co., Ltd. is a prominent provider of ophthalmic... Aier Eye Hospital Group Co., Ltd. is a prominent provider of ophthalmic healthcare services and institutions. Its comprehensive medical offerings encompass specialties such as the diagnosis and treatment of fundus diseases, optometry, refractive correction, glaucoma, corneal conditions, and cataracts. Beyond direct patient care, the company also conducts training courses focused on cataract prevention and management. The group boasts an extensive international footprint, operating approximately 500 ophthalmic facilities across mainland China, with additional presences including 86 in Europe, 1 in the United States, 7 in Hong Kong, and 12 throughout Southeast Asia. Founded in 2007, Aier Eye Hospital Group maintains its headquarters in Changsha, China.
株価
$1.15
時価総額
$10.73B
変化（1日）
0.25%
変化（1年）
-33.37%
国
CN
取引 Aier Eye Hospital Group Co., Ltd. (300015)
カテゴリー
Healthcare
Aier Eye Hospital Group Co., Ltd.（300015）の利益
Jun 2026 時点の利益 TTM: $631.57M
Aier Eye Hospital Group Co., Ltd. の最新の財務報告によると、同社の現在の利益は $631.57M です。2023 年には $642.93M の利益を上げ、これは 2022 年の利益 $483.49M と 増加 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Aier Eye Hospital Group Co., Ltd. の利益の推移（2006 〜 2026）
各年末の利益
| 年 | 利益 | 変化 |
|---|---|---|
| 2026 (TTM) | $631.57M | 0.34% |
| 2024 | $629.43M | -2.10% |
| 2023 | $642.93M | 32.98% |
| 2022 | $483.49M | -2.37% |
| 2021 | $495.25M | 36.90% |
| 2020 | $361.76M | 36.89% |
| 2019 | $264.28M | 31.71% |
| 2018 | $200.65M | 27.11% |
| 2017 | $157.86M | 60.30% |
| 2016 | $98.48M | 16.24% |
| 2015 | $84.72M | 28.91% |
| 2014 | $65.72M | 30.75% |
| 2013 | $50.27M | 27.20% |
| 2012 | $39.52M | 3.86% |
| 2011 | $38.05M | 40.56% |
| 2010 | $27.07M | 48.66% |
| 2009 | $18.21M | 70.18% |
| 2008 | $10.70M | 63.21% |
| 2007 | $6.56M | 166.97% |
| 2006 | $2.46M | 0.00% |
同業他社の利益
| 企業 | 利益 | 利益の差 | 国 |
|---|---|---|---|
| $9.87B | 1,462.94% |
US
|
|
| - | - |
DE
|
|
| $3.87B | 511.97% |
US
|
|
| $687.82M | 8.91% |
SA
|
|
| $1.25B | 97.40% |
BR
|
